REVAMP-Follow-Up Study
REVAMP-Follow-Up Study
批准号:
7271240
负责人:
ALAN F. SCHATZBERG
金额:
$6.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-01 至 2009-06-30
关键词:
AccountingAcuteAddressAdverse effectsAftercareAlgorithmsAmericanBehavioralChronicClinical ManagementCognitiveCognitive TherapyConditionConsentDataDepressed moodDisease remissionEducational process of instructingFollow-Up StudiesFundingGoalsGroup PsychotherapyGuidelinesLong-Term EffectsMaintenanceMajor Depressive DisorderMediatingMental DepressionNational Institute of Mental HealthOutcomePatientsPharmaceutical PreparationsPharmacotherapyPhaseProblem SolvingPsychotherapyRandomizedRateRecurrenceRelapseResearchResearch PersonnelResistanceRiskSamplingSiteSocial AdjustmentSocial FunctioningSocial ProblemsStagingSymptomsSystems AnalysisTestingTimeWeekWithholding Treatmentchronic depressioncompliance behaviordepressive symptomsfallsfollow-upprogramsresponseskills
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of the ongoing NIMH funded multi-site study entitled "Research Evaluating the Effect of Augmenting Medication with Psychotherapy" (REVAMP) is to investigate psychotherapeutic strategies for treating chronic forms of major depression unresponsive to medication alone. Patients (n = 909) are treated initially with one of several pharmacologic strategies, as guided by a staged algorithm. Those who do not remit after up to 12 weeks of treatment (estimated n = 500) receive the next algorithm-guided pharmacotherapy. In addition they are randomized to Cognitive Behavioral Analysis System of Psychotherapy (CBASP), Supportive Psychotherapy (SP), or Clinical Management (CM). At exit from this 12-week randomized therapy trial all consenting patients enter a 24-month naturalistic follow-up to investigate the durability of the acute approaches in keeping patients well. It is hypothesized that patients who received augmentation with CBASP in addition to switching medication will have better long-term outcomes (e.g., more time in remission, lower symptom ratings, better social adjustment) than patients receiving a medication switch alone, and patients who received SP augmentation will fall in between. We also hope to test whether the long-term effects of CBASP are mediated by teaching patients more effective social problem-solving skills. We now are submitting a competing continuation application to complete the final 3 years of the follow-up. Some prior studies have showed enduring effects of psychotherapy in depressed patients (although not in chronic forms of MOD), but other studies have failed to find such an effect, including the NIMH Collaborative Treatment Study. This follow-up study will address the important question of whether augmentation with 12 weeks of CBASP, a therapy developed specifically for chronic depression, leads to enduring effects in a chronic sample over that provided by pharmacotherapy alone or in combination with a less specific form of psychotherapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Biobehavioral Research Training Program
-
批准号:9404690
-
项目类别:
-
资助金额:$0.95万
-
财政年份:2016
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
Stanford Mood Disorders Center: Enhancing Core Clinical Research Resources
-
批准号:7941055
-
项目类别:
-
资助金额:$80.0万
-
财政年份:2009
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
Stanford Mood Disorders Center: Enhancing Core Clinical Research Resources
-
批准号:7858970
-
项目类别:
-
资助金额:$76.58万
-
财政年份:2009
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
HPA AXIS/SLEEP/GCRC
-
批准号:7605180
-
项目类别:
-
资助金额:$4.92万
-
财政年份:2007
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
OPEN-LABEL TREATMENT OF SCHIZOFFECTIVE DISORDER USING MIFEPRISTONE
-
批准号:7375188
-
项目类别:
-
资助金额:$1.82万
-
财政年份:2005
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
HPA AXIS/SLEEP/GCRC
-
批准号:7375225
-
项目类别:
-
资助金额:$3.25万
-
财政年份:2005
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
HPA AXIS/SLEEP/NORMALS
-
批准号:7202103
-
项目类别:
-
资助金额:$1.17万
-
财政年份:2004
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
HPA AXIS/SLEEP/GCRC
-
批准号:7202070
-
项目类别:
-
资助金额:$1.04万
-
财政年份:2004
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
An Open-Label Study of the Treatment of Schizoaffective Disorder and Psychotic
-
批准号:6980884
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2003
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
Core--Recruitment
-
批准号:6653356
-
项目类别:
-
资助金额:$15.93万
-
财政年份:2002
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
REVAMP-Follow-Up Study
-
批准号:7448439
-
项目类别:
-
资助金额:$5.95万
-
财政年份:2002
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
CBASP Augmentation for Treatment of Chronic Depression
-
批准号:6665450
-
项目类别:
-
资助金额:$30.06万
-
财政年份:2002
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
CBASP Augmentation for Treatment of Chronic Depression
-
批准号:6755141
-
项目类别:
-
资助金额:$38.89万
-
财政年份:2002
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
CBASP Augmentation for Treatment of Chronic Depression
-
批准号:6434841
-
项目类别:
-
资助金额:$26.88万
-
财政年份:2002
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
CBASP Augmentation for Treatment of Chronic Depression
-
批准号:6910016
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2002
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
Core--Recruitment
-
批准号:6485297
-
项目类别:
-
资助金额:$15.93万
-
财政年份:2001
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
COGENT TO SUPPORT CLINICAL RESEARCH AT STANFORD
-
批准号:6193789
-
项目类别:
-
资助金额:$47.78万
-
财政年份:2000
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
RAPID REVERSAL OF PSYCHOTIC MAJOR DEPRESSION USING RU 486
-
批准号:6486061
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2000
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
COGENT TO SUPPORT CLINICAL RESEARCH AT STANFORD
-
批准号:6653186
-
项目类别:
-
资助金额:$48.54万
-
财政年份:2000
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
COGENT TO SUPPORT CLINICAL RESEARCH AT STANFORD
-
批准号:6528808
-
项目类别:
-
资助金额:$48.75万
-
财政年份:2000
-
负责人:ALAN F. SCHATZBERG
-
依托单位:
海外基金